206 related articles for article (PubMed ID: 19132956)
1. A common variant of the eNOS gene (E298D) is an independent risk factor for left ventricular hypertrophy in human essential hypertension.
Xin Y; Song X; Xue H; Liu Z; Wang X; Wang H; Sun K; Bai Y; Liu J; Hui R
Clin Sci (Lond); 2009 Jun; 117(2):67-73. PubMed ID: 19132956
[TBL] [Abstract][Full Text] [Related]
2. The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease.
Talmud PJ; Flavell DM; Alfakih K; Cooper JA; Balmforth AJ; Sivananthan M; Montgomery HE; Hall AS; Humphries SE
Clin Sci (Lond); 2007 Jun; 112(12):617-24. PubMed ID: 17291198
[TBL] [Abstract][Full Text] [Related]
3. Lack of association of G-protein subunit gene C825T polymorphism with left ventricular hypertrophy in essential hypertension.
Shlyakhto EV; Shwartz EI; Nefedova YB; Zukova AV; Vinnic TA; Konrady AO
Med Sci Monit; 2002 May; 8(5):CR337-40. PubMed ID: 12011775
[TBL] [Abstract][Full Text] [Related]
4. Association of beta 1-adrenergic receptor gene polymorphisms with left ventricular hypertrophy in human essential hypertension.
Fu C; Wang H; Wang S; Shi Y; Zhou X; Sun K; Chen J; Song X; Xue H; Hui R
Clin Biochem; 2008 Jul; 41(10-11):773-8. PubMed ID: 18298953
[TBL] [Abstract][Full Text] [Related]
5. ENOS-G894T polymorphism is a risk factor for essential hypertension in China.
Men C; Tang K; Lin G; Li J; Zhan Y
Indian J Biochem Biophys; 2011 Jun; 48(3):154-7. PubMed ID: 21793305
[TBL] [Abstract][Full Text] [Related]
6. [Clinico-genetic aspects of the hypotensive response and regression of left ventricular hypertrophy in arterial hypertension patients].
Moiseev VS; Kotovskaia IuV; Kobalava ZhD; Nosikov VV; Korovina EP; Timofeeva SG
Ter Arkh; 2002; 74(10):30-7. PubMed ID: 12469628
[TBL] [Abstract][Full Text] [Related]
7. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
Iaccarino G; Izzo R; Trimarco V; Cipolletta E; Lanni F; Sorriento D; Iovino GL; Rozza F; De Luca N; Priante O; Di Renzo G; Trimarco B
Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical correlates of right ventricular hypertrophy in essential hypertension.
Cuspidi C; Negri F; Giudici V; Valerio C; Meani S; Sala C; Esposito A; Masaidi M; Zanchetti A; Mancia G
J Hypertens; 2009 Apr; 27(4):854-60. PubMed ID: 19516183
[TBL] [Abstract][Full Text] [Related]
9. Association of insulin-like growth factor-1 receptor gene polymorphisms with left ventricular mass and geometry in essential hypertension.
Horio T; Kamide K; Takiuchi S; Yoshii M; Miwa Y; Matayoshi T; Yoshihara F; Nakamura S; Tokudome T; Miyata T; Kawano Y
J Hum Hypertens; 2010 May; 24(5):320-6. PubMed ID: 19759555
[TBL] [Abstract][Full Text] [Related]
10. Role of the angiotensin II type 2 receptor gene (+1675G/A) polymorphism on left ventricular hypertrophy and geometry in treated hypertensive patients.
Huber M; Völler H; Jakob S; Reibis R; Do V; Bolbrinker J; Zergibel I; Schmieder RE; Treszl A; Wegscheider K; Kreutz R
J Hypertens; 2010 Jun; 28(6):1221-9. PubMed ID: 20467270
[TBL] [Abstract][Full Text] [Related]
11. Endothelial nitric oxide synthase gene (NOS3) variant and hypertension in pregnancy.
Kobashi G; Yamada H; Ohta K; Kato E; Ebina Y; Fujimoto S
Am J Med Genet; 2001 Oct; 103(3):241-4. PubMed ID: 11745998
[TBL] [Abstract][Full Text] [Related]
12. [ACE and AGTR1 genes polymorphisms in left ventricular hypertrophy pathogenesis in humans].
Makeeva OA; Puzyrev KV; Pavliukova EN; Koshel'skaia OA; Golubenko MV; Efimova EV; Kucher AN; Tsimbaliuk IV; Karpov RS; Puzyrev VP
Mol Biol (Mosk); 2004; 38(6):990-6. PubMed ID: 15612584
[TBL] [Abstract][Full Text] [Related]
13. Epicardial coronary artery size in hypertensive and physiologic left ventricular hypertrophy.
Kozakova M; Paterni M; Bartolomucci F; Morizzo C; Rossi G; Galetta F; Palombo C
Am J Hypertens; 2007 Mar; 20(3):279-84. PubMed ID: 17324740
[TBL] [Abstract][Full Text] [Related]
14. The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis.
Yao L; Fang F; Zhong Y; Yu L
Breast Cancer Res Treat; 2010 Nov; 124(1):223-7. PubMed ID: 20204503
[TBL] [Abstract][Full Text] [Related]
15. Effect of polymorphisms of endothelial nitric oxide synthase on ischemic stroke: a case-control study in a Chinese population.
Cheng J; Liu J; Li X; Yu L; Peng J; Zhang R; Geng Y; Nie S
Clin Chim Acta; 2008 Jun; 392(1-2):46-51. PubMed ID: 18396156
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between serum leptin levels and left ventricular hypertrophy in obese hypertensive patients].
Kartal O; Inal V; Baysan O; Sağlam K
Anadolu Kardiyol Derg; 2008 Oct; 8(5):342-6. PubMed ID: 18849224
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide linkage analysis of electrocardiographic and echocardiographic left ventricular hypertrophy in families with hypertension.
Mayosi BM; Avery PJ; Farrall M; Keavney B; Watkins H
Eur Heart J; 2008 Feb; 29(4):525-30. PubMed ID: 18276622
[TBL] [Abstract][Full Text] [Related]
18. G-protein beta-3 subunit gene 825C>T dimorphism is associated with left ventricular hypertrophy but not essential hypertension.
Mahmood MS; Mian ZS; Afzal A; Frossard PM
Med Sci Monit; 2005 Jan; 11(1):CR6-9. PubMed ID: 15614196
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide gene promoter polymorphism is associated with left ventricular hypertrophy in hypertension.
Xue H; Wang S; Wang H; Sun K; Song X; Zhang W; Fu C; Han Y; Hui R
Clin Sci (Lond); 2008 Jan; 114(2):131-7. PubMed ID: 17672826
[TBL] [Abstract][Full Text] [Related]
20. No association of the CYP3A5*1 allele with blood pressure and left ventricular mass and geometry: the KORA/MONICA Augsburg echocardiographic substudy.
Lieb W; Bolbrinker J; Döring A; Hense HW; Erdmann J; Schunkert H; Kreutz R
Clin Sci (Lond); 2006 Dec; 111(6):365-72. PubMed ID: 16822233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
